Heidtman Steel to Build Ultra High Strength Steel Production Facility

Heidtman Steel Products Inc. - an industry leader in steel sales and processing with direct and joint venture production facilities totaling over two million square feet and serving over 1,200 customers in a variety of industries - is finalizing plans to construct a new continuous annealing (CAL) facility. "We have completed a lengthy study and are moving forward with our plans to construct this facility" states John Dillingham, Heidtman's Director of Technical Services for Automotive Products. The facility will be capable of producing advanced (AHSS) and ultra high strength steels (UHSS) including martensitic grades. With a capacity of 500,000 short tons per year, it will produce material thicknesses from .015" to .090" (.4 to 2.3mm) to a maximum width of 65" (1651mm).

According to John Bates, Chief Executive Officer of Heidtman, "Our plan to build a new continuous annealing facility is a natural progression with higher strength steels, and reinforces our brand as the high strength experts. It also underscores our commitment to our customers to remain at the cutting edge of technology. We see an emerging growth in demand for these products, especially in the automotive market."

Heidtman is looking at several Midwest locations for this project which will cost approximately $225,000,000 including downstream processing equipment. It is estimated the project will create 200 jobs. Putting an emphasis on logistical advantages, Heidtman is looking primarily at sites in Ohio, Michigan and Indiana, but has not ruled out other locations including the southern U.S. due to the growing number of automotive plants in that region.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.